FEDERATED HERMES, INC. - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 18 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2022$29,880
-28.9%
60,0000.0%0.00%
Q3 2022$42,000
-20.8%
60,0000.0%0.00%
Q2 2022$53,000
-20.9%
60,0000.0%0.00%
Q1 2022$67,000
-15.2%
60,000
+50.0%
0.00%
Q4 2021$79,000
-23.3%
40,000
+33.3%
0.00%
Q3 2021$103,000
+5.1%
30,000
+150.0%
0.00%
Q2 2021$98,000
-60.2%
12,000
-40.0%
0.00%
Q1 2021$246,000
-32.6%
20,0000.0%0.00%
-100.0%
Q4 2020$365,000
+17.0%
20,0000.0%0.00%0.0%
Q3 2020$312,00020,0000.00%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q2 2022
NameSharesValueWeighting ↓
CHI Advisors LLC 1,361,064$24,853,0007.00%
Novo Holdings A/S 2,361,229$43,116,0001.85%
Ally Bridge Group (NY) LLC 425,000$7,761,0001.33%
TFG Asset Management GP Ltd 750,000$13,695,0000.92%
SECTORAL ASSET MANAGEMENT INC 657,494$12,006,0000.85%
FRAZIER MANAGEMENT LLC 550,000$10,043,0000.77%
Eventide Asset Management 2,485,656$44,266,0000.68%
Ovata Capital Management Ltd 14,981$274,0000.09%
AXA S.A. 551,476$10,070,0000.03%
Woodline Partners LP 25,932$474,0000.01%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders